Qinlock Side Effects Center

Last updated on RxList: 10/3/2022
Qinlock Side Effects Center

What Is Qinlock?

Qinlock (ripretinib) is a kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

What Are Side Effects of Qinlock?

Side effects of Qinlock include:

Seek medical care or call 911 at once if you have the following serious side effects:

  • Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
  • Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheadedness, or passing out;
  • Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.

Dosage for Qinlock

The recommended dosage of Qinlock is 150 mg orally once daily with or without food.

Qinlock In Children

The safety and effectiveness of Qinlock in pediatric patients have not been established.

What Drugs, Substances, or Supplements Interact with Qinlock?

Qinlock may interact with other medicines such as:

  • itraconazole

Tell your doctor all medications and supplements you use.

Qinlock During Pregnancy and Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant before using Qinlock; it may harm a fetus. Females of reproductive potential and males with female partners of reproductive potential are advised to use effective contraception during treatment and for at least 1 week after the final dose. It is unknown if Qinlock passes into breast milk. Because of the potential for serious adverse reactions in the breastfed child, breastfeeding is not recommended while using Qinlock and for at least 1 week after the final dose.

Additional Information

Our Qinlock (ripretinib) Tablets, for Oral Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

Skin Cancer Symptoms, Types, Images See Slideshow
Qinlock Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • severe stomach pain, nausea, or vomiting;
  • severe headache, blurred vision, pounding in your neck or ears;
  • pain, blisters, bleeding, or severe rash in the palms of your hands or the soles of your feet;
  • heart problems--tiredness, feeling short of breath, swollen veins in the sides of your neck, swelling in your stomach or lower legs;
  • low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or
  • skin changes--a new wart, a skin sore or red bump that bleeds or does not heal, or any change in the size or color of a mole.

Common side effects may include:

  • nausea, vomiting, stomach pain, loss of appetite;
  • diarrhea, constipation;
  • tiredness;
  • muscle pain;
  • thinning hair, hair loss;
  • abnormal blood tests; or
  • severe rash on your hands or feet.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Qinlock Professional Information

Read the entire FDA prescribing information for Qinlock (Ripretinib Tablets )

© Qinlock Patient Information is supplied by Cerner Multum, Inc. and Qinlock Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors